Health Care Originals

“When you can’t breathe, nothing else matters.”

That’s the position of Sharon Samjitsingh, co-founder and CEO of a fast-growing health tech company called Health Care Originals (HCO).

HCO is on a mission to revolutionize the eighty-three-billion-dollar respiratory-care market. It’s created an Artificial Intelligence-powered virtual respiratory-care platform that is bringing continuous, personalized care for the 690 million sufferers of asthma and chronic obstructive pulmonary disease (COPD) — the third-leading cause of death globally.

Every day in the U.S., there are 30,000 asthma attacks, 15,600 COPD office visits, and 430 respiratory-related deaths.

Chronic respiratory conditions affect people of all ages. And those living with these conditions struggle with daily tasks as flare-ups lead to heightened anxiety, panic, and frequent hospital visits. Forty-seven billion dollars in avoidable costs are spent each year on related hospital and doctor’s visits associated with respiratory conditions.

Medication isn’t always effective for these people. Neither is a one-size-fits-all approach to healthcare. What’s the solution?

HCO has created a virtual platform and smart wearable that offers unique insights and actionable data, enabling wearers to take control of their respiratory care. Here’s how it works:

Users wear an undetectable device that is attached to the body. This device continuously tracks and analyzes respiratory health by listening to deep organ sounds — the first company in the world to take this approach — and these sounds create important digital biomarkers.

Users are alerted to predictive and actionable insights to prevent flare-ups, while respiratory therapists and health coaches monitor the data and offer ongoing support.

HCO has achieved notable efficacy. Within six months, 100% of users reported reduced wheezing and shortness of breath. Ninety percent reported improved sleep and sixty-seven percent experienced no attacks at all.

HCO is backed by venture-capital funds Safar Partners and Chloe Capital. And it has signed contracts valued at $5.5 million in projected annual-recurring revenue, based on recruiting just four percent of the total customers available to the company. The company has a wait list of more than 12,000 potential users.

HCO projects to surpass five million dollars in revenue this year and thirty-four million dollars in revenue in 2026.

HCO’s profit potential is notable. Similar health tech companies have transitioned care from high-cost medical interventions such as surgeons and clinical visits to more scalable expert care delivered through digital channels. And many have become multi-billion-dollar businesses as a result.

Furthermore, recent strategic acquisitions of health devices highlight the demand for innovative solutions, such as HCO’s platform.

Team Background

Sharon Samjitsingh - Co-Founder & CEO

Sharon is a healthcare-industry veteran who has been named among the Top 100 women in health tech.

In addition to her role with HCO, she is a member of the Women Business Leaders of the U.S. Health Care Industry Foundation, a healthcare-related non-profit. Previously, she spent ten years with Sweetwater Energy, a renewable-energy company, as a project manager and Director of Commercialization.

Earlier in her career, Sharon helped drive revenue growth by twenty times at a previous company, and she led a $150 million portfolio at a seven-billion-dollar conglomerate. Throughout her career, she has received seven healthcare-related patents.

She earned a Bachelor’s degree in Chemical and Process Engineering from the University of the West Indies and a Master’s degree in Technical Entrepreneurship and Management from the University of Rochester.

Jared Dwarika - Co-Founder & COO

Jared has twenty years of experience selling devices. Throughout his career, he has been issued ten healthcare-related patents.

Early in his career, he was an engineering manager with Alstons Building Enterprises, an engineering company. He then was Sales and Marketing Coordinator with Western Scientific Company, where he grew sales by 30x within five years.

In addition to his role with HCO, Jared is a featured speaker at MEDICA, the world’s leading event for featuring medical devices. He holds an MBA from Henley Business School.

Jennifer Chambers - Chief Medical Officer

Jennifer is a senior-physician executive with clinical, managerial, and leadership experience.

Previously, she was Senior Medical Director with Capital Blue Cross, a healthcare company, where she also spent a decade as Senior Vice President and Chief Medical Officer. Before that, she was an assistant professor of Medicine at Penn State’s Hershey Medical Center.

Earlier in her career, Jennifer was an associate chief of staff with Lebanon Vamc, a healthcare company. She earned a Bachelor’s degree in Clinical Laboratory Science from Millersville University, and an MBA and M.D. from Penn State University.

Co-Investors

Safar Partners

A venture fund investing in technology companies sprung from MIT and Harvard.

Chloe Capital

A seed-stage venture firm investing in woman-led startups.